{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T16:56:15Z","timestamp":1758473775860,"version":"3.44.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1016\/j.amjmed.2003.09.021","type":"journal-article","created":{"date-parts":[[2003,12,18]],"date-time":"2003-12-18T05:35:35Z","timestamp":1071725735000},"page":"708-714","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prediction of outcome after percutaneous coronary intervention for the acute coronary syndrome"],"prefix":"10.1016","volume":"115","author":[{"given":"Annapoorna S","family":"Kini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul C","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina A","family":"Mitre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael C","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mazullah","family":"Kamran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary E","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan D","family":"Marmur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samin K","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2003.09.021_BIB1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1053\/euhj.2001.2904","article-title":"Risk stratification and treatment benefits in patients with non-ST-elevation acute coronary syndromes","volume":"23","author":"White","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjmed.2003.09.021_BIB2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/euhj.2001.2738","article-title":"An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes","volume":"23","author":"Morrow","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjmed.2003.09.021_BIB3","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/jama.284.7.835","article-title":"The TIMI risk score for unstable angina\/non-ST elevation MI. A method for prognostication and therapeutic decision making","volume":"284","author":"Antman","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2003.09.021_BIB4","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0002-9149(01)02089-6","article-title":"A risk stratification scheme for selection of a glycoprotein IIb\/IIIa inhibitor during percutaneous coronary intervention based on clinical and angiographic criteria","volume":"88","author":"Kini","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjmed.2003.09.021_BIB5","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1161\/01.CIR.100.19.1971","article-title":"Relation between lesion characteristics and risk with percutaneous intervention in the stent and glycoprotein IIb\/IIIa era","volume":"100","author":"Ellis","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2003.09.021_BIB6","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0735-1097(99)00298-3","article-title":"Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course","volume":"34","author":"Kini","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2003.09.021_BIB7","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1161\/01.CIR.100.24.2400","article-title":"Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality","volume":"100","author":"Hong","year":"1999","journal-title":"Circulation"},{"year":"2000","series-title":"Applied Logistic Regression","author":"Hosmer","key":"10.1016\/j.amjmed.2003.09.021_BIB8"},{"key":"10.1016\/j.amjmed.2003.09.021_BIB9","first-page":"10","article-title":"Recursive Partitioning in the Health Sciences","author":"Zhang","year":"1999"},{"key":"10.1016\/j.amjmed.2003.09.021_BIB10","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.amjmed.2003.09.021_BIB11","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0735-1097(99)00267-3","article-title":"Multivariate prediction of in-hospital mortality after percutaneous coronary interventions in 1994-1996. Northern New England Cardiovascular Disease Study Group","volume":"34","author":"O'Connor","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2003.09.021_BIB12","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0735-1097(02)01731-X","article-title":"Development of a risk adjustment mortality model using the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) experience","volume":"39","author":"Shaw","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2003.09.021_BIB13","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1161\/01.CIR.104.3.263","article-title":"Simple bedside additive tool for prediction of in-hospital mortality after percutaneous coronary interventions","volume":"104","author":"Moscucci","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2003.09.021_BIB14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0735-1097(02)01980-0","article-title":"Correlates of procedural complications and a simple integer risk score for percutaneous coronary intervention","volume":"40","author":"Singh","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2003.09.021_BIB15","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0002-9149(02)02654-1","article-title":"Usefulness of the TIMI risk score in predicting both short- and long-term outcomes in the Veterans Affairs Non-Q-Wave Myocardial Infarction Strategies In-Hospital (VANQWISH) Trial","volume":"90","author":"Samaha","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjmed.2003.09.021_BIB16","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0140-6736(99)07349-3","article-title":"Invasive compared with non-invasive treatment in unstable coronary artery disease","volume":"354","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2003.09.021_BIB17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0140-6736(98)06113-3","article-title":"Randomized placebo-controlled and balloon angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb\/IIIa blockade","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2003.09.021_BIB18","doi-asserted-by":"crossref","unstructured":"The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494-502","DOI":"10.1056\/NEJMoa010746"},{"key":"10.1016\/j.amjmed.2003.09.021_BIB19","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/S0140-6736(00)03400-0","article-title":"Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT)","volume":"356","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2003.09.021_BIB20","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJM200106213442502","article-title":"Comparison of two platelet glycoprotein IIb\/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization","volume":"344","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2003.09.021_BIB21","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(96)10452-9","article-title":"Randomized placebo-controlled trial of abciximab before and during intervention in refractory unstable angina","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2003.09.021_BIB22","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199808133390704","article-title":"Inhibition of glycoprotein IIb\/IIIa with eptifibatide in patients with acute coronary syndromes","volume":"339","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2003.09.021_BIB23","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1056\/NEJM199805213382102","article-title":"Inhibition of the platelet glycoprotein IIb\/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction","volume":"338","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2003.09.021_BIB24","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJM200106213442501","article-title":"Comparison of early invasive and conservatives strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb\/IIIa inhibitor tirofiban","volume":"334","author":"Cannon","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2003.09.021_BIB25","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/01.CIR.0000012783.63093.0C","article-title":"Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts","volume":"105","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2003.09.021_BIB26","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1161\/01.CIR.0000017635.82128.8C","article-title":"Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb\/IIIa inhibitors in patients undergoing coronary stenting","volume":"105","author":"Stone","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2003.09.021_BIB27","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0002-9149(02)02528-6","article-title":"Effectiveness of tirofiban, eptifibatide, and abciximab in minimizing myocardial necrosis during percutaneous coronary intervention (TEAM pilot study)","volume":"90","author":"Kini","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjmed.2003.09.021_BIB28","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/01.CIR.102.2.166","article-title":"Cardioprotective effect of prior \u03b2-blocker therapy in reducing creatine kinase-MB elevation after coronary intervention. Benefit is extended to improvement in intermediate-term survival","volume":"102","author":"Sharma","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2003.09.021_BIB29","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1161\/hc0602.103586","article-title":"Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention","volume":"105","author":"Chan","year":"2002","journal-title":"Circulation"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934303006016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934303006016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:26:32Z","timestamp":1757579192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934303006016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S0002934303006016"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2003.09.021","relation":{},"ISSN":["0002-9343"],"issn-type":[{"type":"print","value":"0002-9343"}],"subject":[],"published":{"date-parts":[[2003,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of outcome after percutaneous coronary intervention for the acute coronary syndrome","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2003.09.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Excerpta Medica Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}